| Abnormal salivary total and oligomeric alpha-synuclein in Parkinson’s disease G Vivacqua, A Latorre, A Suppa, M Nardi, S Pietracupa, R Mancinelli, ... PloS one 11 (3), e0151156, 2016 | 82 | 2016 |
| Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms S Pietracupa, A Fasano, G Fabbrini, M Sarchioto, M Bloise, A Latorre, ... Parkinsonism & Related Disorders 19 (11), 1004-1008, 2013 | 57 | 2013 |
| Fatigue in Parkinson's disease: motor or non-motor symptom? G Fabbrini, A Latorre, A Suppa, M Bloise, M Frontoni, A Berardelli Parkinsonism & related disorders 19 (2), 148-152, 2013 | 53 | 2013 |
| Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up M Sensi, G Cossu, F Mancini, M Pilleri, M Zibetti, N Modugno, R Quatrale, ... Parkinsonism & related disorders 38, 90-92, 2017 | 46 | 2017 |
| Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study A Tessitore, P Marano, N Modugno, FE Pontieri, N Tambasco, M Canesi, ... Journal of neurology 265 (5), 1124-1137, 2018 | 43 | 2018 |
| The use of transcranial magnetic stimulation as a treatment for movement disorders: a critical review A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell Movement Disorders 34 (6), 769-782, 2019 | 41 | 2019 |
| Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky … CR Fabbrini G, Abbruzzese G, Barone P, Antonini A, Tinazzi M, Castegnaro G ... Neurological Science 34 (11), 2015-22, 2013 | 39 | 2013 |
| The interindividual variability of transcranial magnetic stimulation effects: implications for diagnostic use in movement disorders A Latorre, L Rocchi, A Berardelli, KP Bhatia, JC Rothwell Movement Disorders 34 (7), 936-949, 2019 | 38 | 2019 |
| Pathophysiology of pain and fatigue in Parkinson's disease A Berardelli, A Conte, G Fabbrini, M Bologna, A Latorre, L Rocchi, ... Parkinsonism & related disorders 18, S226-S228, 2012 | 38 | 2012 |
| Non-invasive suppression of essential tremor via phase-locked disruption of its temporal coherence SR Schreglmann, D Wang, RL Peach, J Li, X Zhang, A Latorre, E Rhodes, ... Nature communications 12 (1), 1-15, 2021 | 28 | 2021 |
| Unravelling the enigma of cortical tremor and other forms of cortical myoclonus A Latorre, L Rocchi, F Magrinelli, E Mulroy, A Berardelli, JC Rothwell, ... Brain 143 (9), 2653-2663, 2020 | 28 | 2020 |
| Primary motor cortex long‐term plasticity in multiple system atrophy A Suppa, L Marsili, F Di Stasio, A Latorre, AK Parvez, C Colosimo, ... Movement Disorders 29 (1), 97-104, 2014 | 28 | 2014 |
| Impaired automatic but intact volitional inhibition in primary tic disorders V Rawji, S Modi, A Latorre, L Rocchi, L Hockey, K Bhatia, E Joyce, ... Brain 143 (3), 906-919, 2020 | 25 | 2020 |
| Ten‐year reflections on the neurophysiological abnormalities of focal dystonias in humans A Conte, L Rocchi, A Latorre, D Belvisi, JC Rothwell, A Berardelli Movement Disorders 34 (11), 1616-1628, 2019 | 23 | 2019 |
| Twenty years on: Myoclonus‐dystonia and ε‐sarcoglycan—neurodevelopment, channel, and signaling dysfunction E Menozzi, B Balint, A Latorre, EM Valente, JC Rothwell, KP Bhatia Movement Disorders 34 (11), 1588-1601, 2019 | 22 | 2019 |
| Motor cortical excitability during voluntary inhibition of involuntary tic movements C Ganos, L Rocchi, A Latorre, L Hockey, C Palmer, EM Joyce, KP Bhatia, ... Movement disorders 33 (11), 1804-1809, 2018 | 22 | 2018 |
| Are studies of motor cortex plasticity relevant in human patients with Parkinson’s disease? M Bologna, A Suppa, A Conte, A Latorre, JC Rothwell, A Berardelli Clinical Neurophysiology 127 (1), 50-59, 2016 | 21 | 2016 |
| Parkinsonian patients and poor awareness of dyskinesias S Pietracupa, A Latorre, A Berardelli, G Fabbrini Frontiers in Neurology 5, 32, 2014 | 21 | 2014 |
| Reappraisal of cortical myoclonus: A retrospective study of clinical neurophysiology A Latorre, L Rocchi, A Berardelli, JC Rothwell, KP Bhatia, C Cordivari Movement Disorders 33 (2), 339-341, 2018 | 18 | 2018 |
| Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study BP Tinazzi M, Abbruzzese G, Antonini A, Ceravolo R, Fabbrini G, Lessi P, ... Parkinsonism and Related Disorderd 19 (12), 1130-5, 2013 | 15* | 2013 |
Kailash BhatiaProfessor of Clinical Neurology, Institute of Neurology, UCL, Queen Square, London WC1N 3BG,Dirección de correo verificada de ucl.ac.uk
